We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy.

What’s powering a $26.28 billion opportunity? The global ophthalmology drugs market, valued at US$18.34 billion in 2024 stood ...

Moderna has a deep pipeline of promising mRNA candidates that stand to boost business. Regeneron is looking at label expansions for its main product as well as clinical progress elsewhere. Here ...

See the latest Regeneron Pharmaceuticals Inc stock price (REGN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Avastin costs around £28 per injection when used off-label as an intravitreal injection for AMD, which compares to a cost of £816 for Eylea and £551 for Lucentis, according to the judicial ...

His record label, Bad Boy Records, is just one source of his former empire. Musicians like Faith Evans, Janelle Monáe, and Machine Gun Kelly were once signed to the label.

Outlook Therapeutics' Lytenava is the first ophthalmic formulation of bevacizumab to be cleared for use by NICE for use in the NHS for wet AMD.

Jul 02, 2025, 10:44 ET Apotex receives Health Canada approval for Aflivu™, a biosimilar to Eylea®, available in pre-filled syringe and vial formats ...